Opus Genetics CFO Sells Shares for Tax Reasons Amid Steady Insider Buying Amid Biotech Volatility
Opus Genetics insider sale: a tax‑related 3,950‑share move highlights stable executive confidence amid volatile biotech markets and early‑stage growth potential.
3 minutes to read